A 5-Amino-1MQ Certificate of Analysis (COA) provides quantitative, lot-specific analytical data verifying the chemical identity, purity profile, and safety parameters of the small molecule NNMT inhibitor. PX1 Research supplies laboratory-grade reagents accompanied by third-party ISO 17025 analytical reports, including high-performance liquid chromatography and mass spectrometry testing.
A 5-Amino-1MQ Certificate of Analysis (COA) provides quantitative, lot-specific analytical data verifying the chemical identity, purity profile, and safety parameters of the small molecule NNMT inhibitor. PX1 Research supplies laboratory-grade reagents accompanied by third-party ISO 17025 analytical reports, including high-performance liquid chromatography and mass spectrometry testing.
A 5-Amino-1MQ Certificate of Analysis is an official analytical document issuing lot-specific empirical data that verifies chemical identity, quantitative purity, and microbial safety. It confirms target identity via mass spectrometry (LC-MS), quantifies chemical purity via reverse-phase high-performance liquid chromatography (RP-HPLC), and measures residual endotoxin levels to ensure strict laboratory research compliance.
For investigators evaluating modern metabolic compounds, reviewing a verified certificate of analysis is essential before initiating in vitro assays or preclinical animal models. Obtaining high-grade 5-Amino-1MQ with third-party analytical documentation guarantees that experimental observations stem directly from the target molecule rather than structural isomers, synthesis artifacts, or heavy metal contaminants.
Within our comprehensive research peptides catalog, PX1 Research enforces rigorous quality control protocols for both peptide chains and synthetic small molecules. Every batch undergoes independent analytical validation, ensuring that researchers receive fully documented compounds with transparent testing metrics.
5-Amino-1MQ (5-amino-1-methylquinolinium) is a selective, membrane-permeable small molecule inhibitor of the enzyme nicotinamide N-methyltransferase (NNMT). NNMT is a cytosolic enzyme responsible for catalyzing the transfer of a methyl group from S-adenosylmethionine (SAM) to nicotinamide (NAM), producing 1-methylnicotinamide (1-MNA). By inhibiting NNMT catalytic activity, 5-Amino-1MQ prevents the irreversible degradation of nicotinamide.
Preclinical studies suggest that reducing NNMT activity leads to intracellular accumulation of direct precursors necessary for the salvage pathway of nicotinamide adenine dinucleotide (NAD+). In rodent models of metabolic dysregulation, administration of NNMT inhibitors has been observed to elevate intracellular NAD+ pools, enhance mitochondrial respiration rates, and alter lipid accumulation pathways. Investigators interested in cellular bioenergetics frequently utilize 5-Amino-1MQ alongside dedicated NAD+ pathway research compounds to isolate key enzymatic regulators.
Because NNMT is heavily expressed in adipose tissue and liver parenchymal cells, small-molecule inhibition represents a primary model for investigating fat-metabolism research. In vitro assays demonstrate that 5-Amino-1MQ suppression of NNMT decreases methyl donor depletion, allowing cells to maintain higher SAM levels and optimize downstream epigenetic and metabolic signalling.
A reliable COA must go beyond basic appearance notes to provide definitive, instrumental validation of the test compound. When reviewing documentation provided by PX1 Research, laboratory procurement specialists evaluate several core criteria to confirm suitability for analytical research.
First, chemical identity must be unambiguously demonstrated through Liquid Chromatography-Mass Spectrometry (LC-MS). The spectrum must display an exact mass peak corresponding to the calculated molecular weight of the 5-amino-1-methylquinolinium cation (C10H11N3, target mass ~174.22 g/mol). Second, purity must be quantified using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC), establishing that the main peak accounts for at least 98% of total integrated peak area.
Third, safety parameters must include quantitative bacterial endotoxin testing (typically via the Limulus Amebocyte Lysate assay) and loss-on-drying or residual solvent screening. Reviewing these metrics within the central PX1 Research library allows scientists to verify batch uniformity prior to experimental deployment.
High-performance liquid chromatography (HPLC) is the gold standard for determining chemical purity in research reagents. During RP-HPLC analysis, the 5-Amino-1MQ sample is dissolved in an appropriate solvent phase, injected onto a non-polar stationary phase column, and eluted using an organic gradient solvent system. A UV-Vis spectrophotometric detector monitors the eluate at specified wavelengths (typically 220 nm and 254 nm).
The resulting chromatogram plots retention time against UV absorbance intensity. A pure sample yields a single sharp, symmetrical peak corresponding to 5-Amino-1MQ. The integration software calculates the area under the curve (AUC) for the main target peak relative to all observed minor peaks. PX1 Research mandates an RP-HPLC purity threshold of ≥98.0%, confirming that trace synthesis byproducts or breakdown products remain well below acceptable thresholds for rigorous quantitative research.
Extraneous peaks on an HPLC chromatogram indicate chemical impurities, such as unreacted quinoline precursors or regioisomers. Inferior material displaying secondary peaks can skew downstream enzymatic assays, leading to non-reproducible baseline measurements in cellular kinetic studies.
While HPLC separates chemical constituents to measure relative purity, it cannot independently prove molecular structure. Mass spectrometry (MS) complements HPLC by measuring the mass-to-charge ratio (m/z) of ionized molecules, providing definitive identity confirmation.
In electrospray ionization mass spectrometry (ESI-MS), 5-Amino-1MQ undergoes soft ionization to generate a distinct molecular ion peak [M]+ matching its cationic structure at 174.2 m/z. The certificate of analysis documents this observed mass alongside the theoretical molecular mass. Alignment between observed and theoretical values proves that the synthesized compound possesses the correct chemical skeleton.
Absence of unexpected adduct peaks or fragment ions in the mass spectrum confirms that the chemical structure has not degraded during purification or storage, guaranteeing structural integrity for demanding in vitro NNMT binding studies.
Bacterial endotoxins—lipopolysaccharides (LPS) derived from the outer membrane of Gram-negative bacteria—are potent inflammatory agents that severely disrupt cell culture systems and animal physiology. Even highly pure chemical compounds can harbour micro-quantities of endotoxins if synthesized or handled without sterile environmental controls.
A complete 5-Amino-1MQ Certificate of Analysis must state the tested endotoxin concentration, expressed in Endotoxin Units per milligram (EU/mg). Standard research protocols dictate that endotoxin levels must remain below strict limits (e.g., <0.05 EU/mg) to prevent non-specific macrophage activation or immune-mediated cytokine release in cell cultures.
PX1 Research conducts rigorous LAL testing on every production lot. Validating low endotoxin parameters ensures that researchers studying mitochondrial respiration or cytokine release observe genuine metabolic responses to NNMT inhibition rather than artifacts caused by biological contaminants.
Preclinical investigation into 5-Amino-1MQ centers primarily on its capacity to modulate cellular bioenergetics and lipid handling without directly interacting with adrenergic receptors or central nervous system pathways. In vitro assays using 3T3-L1 adipocytes demonstrate that NNMT inhibition increases intracellular NAD+ levels and drives upregulation of GLUT4 transporter expression.
In diet-induced obese rodent models, animal studies indicate that administration of 5-Amino-1MQ led to significant reductions in white adipose tissue volume, reduced adipocyte cell size, and improved systemic insulin sensitivity compared to control groups. These physiological shifts occurred alongside enhanced resting metabolic rate and altered expression of genes governing fatty acid oxidation.
Researchers also utilize 5-Amino-1MQ in comparative studies investigating muscle stem cell proliferation and tissue regeneration. In senescent muscle fiber models, NNMT suppression was observed to restore NAD+ availability, enhancing satellite cell activation and supporting mitochondrial structural integrity during high-load exertion protocols.
5-Amino-1MQ is typically supplied as a crystalline salt (such as the iodide or chloride salt) in a lyophilized or solid powder form. Proper handling procedures must be followed to maintain chemical stability and prevent premature compound degradation upon arrival at the research facility.
For long-term storage, solid 5-Amino-1MQ should be stored at -20°C in a desiccated environment protected from direct light exposure. When preparing stock solutions for in vitro use, dimethyl sulfoxide (DMSO) or high-purity sterile water serves as an appropriate solvent, achieving solubility concentrations up to 10–20 mM depending on temperature and salt form.
Reconstituted liquid solutions should be aliquoted into single-use microcentrifuge tubes to avoid repeated freeze-thaw cycles, which can induce hydrolytic degradation. Working stock solutions stored at 4°C should be utilized within 24 to 48 hours to maintain exact concentration accuracy during enzymatic rate assays.
When designing protocols to investigate cellular energy expenditure and mitochondrial biogenesis, researchers frequently evaluate 5-Amino-1MQ alongside other targeted metabolic modifiers. While 5-Amino-1MQ functions specifically as a direct NNMT enzyme inhibitor, alternative compounds target distinct points in cellular signalling cascades.
For instance, researchers compare the small-molecule action of 5-Amino-1MQ against mitochondrial-derived peptides like MOTS-c, which acts as an AMPK activator to regulate folate cycle dynamics and insulin sensitivity. Similarly, synthetic REV-ERB agonists such as SLU-PP-332 target nuclear receptors to upregulate oxidative muscle fiber phenotypes and mitochondrial density.
Unlike broad AMPK activators or nuclear receptor agonists, 5-Amino-1MQ provides a highly specific mechanism by preserving the intracellular NAD+ precursor pool through targeted enzyme inhibition. Selecting the appropriate compound—or designing dual-inhibition assays—depends on whether the study aims to isolate methyl-donor kinetics, mitochondrial peptide signaling, or circadian metabolic regulation.
Sourcing raw materials for laboratory research requires absolute confidence in supplier integrity, batch consistency, and analytical transparency. PX1 Research operates state-of-the-art, GMP-compliant facilities within the USA, adhering strictly to ISO 17025 laboratory standards for sample preparation and testing.
Every production batch of 5-Amino-1MQ undergoes individual lot tracing, ensuring that the physical vial delivered to your facility directly corresponds to the public third-party COA. All orders ship rapidly from our California and Arizona fulfillment centers, maintaining proper temperature controls during transit.
For institutional laboratories, universities, and high-throughput screening facilities requiring bulk procurement, PX1 Research provides dedicated wholesale lab accounts. Our technical support team remains available to provide raw analytical data files, chromatograms, and mass spectra upon request to support your compliance verification processes.
What does a 5-Amino-1MQ Certificate of Analysis guarantee?
A 5-Amino-1MQ Certificate of Analysis (COA) guarantees lot-specific analytical verification of chemical identity (via LC-MS), quantitative purity (via RP-HPLC ≥98%), molecular weight, and biological safety limits including bacterial endotoxins.
How is the purity of 5-Amino-1MQ measured?
Purity is measured using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC). The main peak area is calculated relative to total integrated peak areas at 220 nm and 254 nm UV wavelengths to establish percentage purity.
What is the primary mechanism of 5-Amino-1MQ in preclinical research?
5-Amino-1MQ is a selective small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT). It prevents the methylation of nicotinamide, preserving NAD+ precursor pools, enhancing intracellular NAD+, and supporting mitochondrial output.
Why is endotoxin testing necessary for 5-Amino-1MQ batches?
Endotoxins (LPS) trigger non-specific inflammatory responses in cellular assays and animal models. COA-verified low endotoxin levels (<0.05 EU/mg) ensure experimental outcomes reflect 5-Amino-1MQ activity rather than bacterial contamination.
How should 5-Amino-1MQ powder be stored in the laboratory?
Lyophilized 5-Amino-1MQ powder should be stored desiccated at -20°C, away from light. Reconstituted stock solutions should be aliquoted and kept frozen to avoid degradation caused by repeated freeze-thaw cycles.
What solvents are suitable for solubilizing 5-Amino-1MQ?
5-Amino-1MQ is readily soluble in dimethyl sulfoxide (DMSO) and sterile aqueous buffers (such as PBS or saline) depending on the salt form and required concentration for in vitro or in vivo research protocols.
Where are PX1 Research compounds manufactured and shipped from?
All PX1 Research compounds are manufactured in USA-based, GMP-compliant facilities and ship directly from our fulfillment hubs in California and Arizona with lot-traceable third-party COAs.
Can institutions purchase bulk quantities of 5-Amino-1MQ?
Yes, verified academic institutions, biotechnology companies, and contract research organizations can access volume supply through PX1 Research wholesale lab accounts.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.